I'm surprised that the market didn't take today's HY21 results as incredibly positive.
Anyone more educated than me have an idea?
With the storm of COVID largely weathered, significant improvements in net operating margin, mention of a dividend on the horizon, and a "low risk" industry in medical supplies, I feel like this is significantly undervalued.
Am I missing something in the report that others are seeing? Genuinely curious, I'm hoping someone more experienced than me can share some insight!
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
39.5¢ |
Change
-0.015(3.66%) |
Mkt cap ! $645.5M | |||
| Open | High | Low | Value | Volume |
| 41.0¢ | 41.0¢ | 38.5¢ | $604.9K | 1.543M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 30211 | 38.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.5¢ | 28453 | 1 |
View Market Depth
| Last trade - 16.10pm 24/06/2025 (20 minute delay) ? |
| PGC (ASX) Chart |